Monopar Therapeutics Inc. buy blaugold
Start price
30.05.23
/
50%
€0.98
Target price
30.05.24
-
Performance (%)
-11.28%
End price
11.06.23
€0.87
Summary
This prediction ended on 11.06.23 with a price of €0.87. The prediction for Monopar Therapeutics Inc. disappointed with a performance of -11.28%. blaugold has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Monopar Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
According to blaugold what are the pros and cons of Monopar Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by blaugold for this prediction
In the thread Monopar Therapeutics Inc. diskutieren
Buy Monopar Therapeutics Inc.